` ICCM (Icecure Medical Ltd) vs S&P 500 Comparison - Alpha Spread

I
ICCM
vs
S&P 500

Over the past 12 months, ICCM has outperformed S&P 500, delivering a return of +25% compared to the S&P 500's +13% growth.

Stocks Performance
ICCM vs S&P 500

Loading
ICCM
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
ICCM vs S&P 500

Loading
ICCM
S&P 500
Difference
www.alphaspread.com

Performance By Year
ICCM vs S&P 500

Loading
ICCM
S&P 500
Add Stock

Competitors Performance
Icecure Medical Ltd vs Peers

Icecure Medical Ltd
Glance View

Market Cap
59.5m USD
Industry
Health Care

IceCure Medical Ltd. is a commercial stage medical device company, which engages in the research and development, design, manufacture, and marketing of cryoablation systems and technologies based on liquid nitrogen for the treatment of tumors. The firm develops and markets minimally invasive cryoablation therapies for women’s health and general oncology market. Icecure Medical Ltd’s proprietary IceSense3 and ProSense systems provide minimally invasive, in-office definitive treatment for symptomatic tumors in various organs. The procedure is done under ultrasound or Computed Tomography (CT) imaging to guide a small probe (thin hollow needle) into the tumor. The system then uses extremely cold temperatures to destroy (ablate) the targeted tumor in situ. Icecure Medical Ltd supports investigator-initiated studies at various academic institutions around the globe, including Kameda and Saint Johns.

ICCM Intrinsic Value
Not Available
I
Back to Top